CCI
36
2
T
23
2
AZO
42
-3
CF
48
4
ACN
56
2
LRCX
62
6
NSC
48
-11
BEN
55
2
AN
50
7
STX
69
2
MCHP
47
-8
WFC
74
5
LNC
75
2
CAG
41
-5
EXPD
51
16
PBI
68
2
PNW
53
-3
ADM
47
2
MHK
43
-2
UNP
38
2
CCI
36
2
T
23
2
AZO
42
-3
CF
48
4
ACN
56
2
LRCX
62
6
NSC
48
-11
BEN
55
2
AN
50
7
STX
69
2
MCHP
47
-8
WFC
74
5
LNC
75
2
CAG
41
-5
EXPD
51
16
PBI
68
2
PNW
53
-3
ADM
47
2
MHK
43
-2
UNP
38
2
Financhill
Back

Mersana Therapeutics, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45

MRSN
Mersana Therapeutics, Inc.

Last Price:
$29.03
Seasonality Move:
13.83%

7 Day Trial

ALL ACCESS PASS

$ 7

Mersana Therapeutics, Inc. Stock Forecast

  • Over the next 52 weeks, Mersana Therapeutics, Inc. has on average historically risen by 28.3% based on the past 8 years of stock performance.
  • Mersana Therapeutics, Inc. has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
  • Is Mersana Therapeutics, Inc. Stock Undervalued?
    The current Mersana Therapeutics, Inc. [MRSN] share price is $28.94. The Score for MRSN is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • MRSN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Mersana Therapeutics, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Mersana Therapeutics, Inc. has on average historically risen by 28.3% based on the past 8 years of stock performance.

Mersana Therapeutics, Inc. Stock Rating

Sell
45
Mersana Therapeutics, Inc. (MRSN) is a Sell

Is Mersana Therapeutics, Inc. overpriced?

  • Mersana Therapeutics, Inc. has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%

Mersana Therapeutics, Inc. Stock Price History

Is MRSN stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRSN is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
mersana.com

52-Week Data

52-Week High:
42.00
52-Week Low:
5.21

Prediction Charts

Market Cap:
144.3M
Price in USD:
28.94
Volume:
85.4K
Beta:
1.47

Technical Analysis

SMA50:
19.08
SMA100:
13.22
SMA200:
11.14
52-Wk Change:
-33.47%

Stock Predictions

  • Is Mersana Therapeutics, Inc. stock public?
    Yes, Mersana Therapeutics, Inc. is a publicly traded company.
  • What is the Mersana Therapeutics, Inc. stock quote today?
    The Mersana Therapeutics, Inc. stock price is 28.94 USD today.
  • How to buy Mersana Therapeutics, Inc. stock online?
    You can buy Mersana Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-2 27.50 27.52 27.69 27.36
Dec-3 27.57 27.85 27.85 27.45
Dec-4 27.90 27.47 28.36 27.31
Dec-5 27.65 27.78 27.97 27.36
Dec-8 28.03 27.92 28.15 27.80
Dec-9 27.85 28.14 28.63 27.85
Dec-10 27.91 28.11 28.59 27.90
Dec-11 28.11 28.23 28.41 28.10
Dec-12 28.38 28.35 28.70 28.11
Dec-15 28.28 28.59 28.80 28.28
Dec-16 28.43 29.05 29.12 28.38
Dec-17 28.56 29.06 29.20 28.55
Dec-18 29.03 29.10 29.10 28.72
Dec-19 29.29 28.94 29.39 28.84

Mersana Therapeutics, Inc. Earnings

Mersana Therapeutics, Inc. Earnings Report: Per Share Mersana Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Mersana Therapeutics, Inc. Forecast Revenue Growth

Mersana Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Mersana Therapeutics, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $2.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $13.34 per share, and a decrease next year of $10.60 per share.

* Mersana Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.